Prediction of tumor doubling time in recurrent meningiomas. Cell kinetics studies with bromodeoxyuridine labeling

Journal of Neurosurgery
K G ChoC B Wilson

Abstract

Eight patients with recurrent meningiomas (four malignant, two hemangiopericytic, and two nonmalignant) were given intravenous bromodeoxyuridine (BUdR), 200 mg/sq m, at the time of surgery to label cells in the deoxyribonucleic acid (DNA) synthesis phase; labeled cells were detected in excised tumor specimens by immunoperoxidase staining using anti-BUdR monoclonal antibody. These tumors showed a wide range of BUdR labeling indices (LI's), calculated as the percentage of BUdR-labeled cells divided by the total number of cells scored, from 0.3% to 5.4%. The tumor doubling times (Td's), estimated from serial computerized tomography scans, ranged from 8 to 440 days and showed a close inverse correlation with the BUdR LI's. A semilogarithmic linear regression analysis of these values yielded a correlation coefficient of 0.99. Tumor doubling time (Td) can be estimated using the formula: Td = 500 X Exp (-0.73 X LI), where Exp signifies the natural log base. By predicting the growth rate of meningiomas, the BUdR LI may supplement histopathological diagnosis and improve both the determination of prognosis and the design of treatment modalities in individual patients.

References

Jan 1, 1975·Journal of Neurology·K Jellinger, F Slowik
Jan 1, 1978·Clinical Neurosurgery·P L Kornblith
Sep 1, 1979·Cancer·T Hoshino, C B Wilson
Sep 1, 1978·American Journal of Clinical Pathology·J R GoellnerH Okazaki
Oct 1, 1975·Cancer·S K LudwinD S Russell
Aug 15, 1986·Cancer·F A Tavassoli
Apr 1, 1986·Journal of Neurosurgery·T NagashimaS J DeArmond
Apr 15, 1985·Cancer·T HoshinoC B Wilson
May 9, 1970·Lancet·W F BenedictR A Florentin
Jan 1, 1974·Acta Neuropathologica·K Skullerud, A C Löken
Feb 1, 1970·Journal of Neurology, Neurosurgery, and Psychiatry·M R Crompton, P C Gautier-Smith
May 1, 1970·Journal of Neurosurgery·D T PitkethlyK M Earle
Feb 1, 1969·Acta Radiologica: Therapy, Physics, Biology·T Hoshino, K Sano
Apr 1, 1967·The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine·M A BagshawT S Nelsen
Dec 1, 1967·Journal of Neurosurgery·J S TytusE Reifel
Jan 1, 1983·Journal of Neurosurgery·A B AdegbiteL K Tan
Dec 1, 1981·Journal of Neurosurgery·H G ThomasK Berry
Feb 1, 1957·Journal of Neurology, Neurosurgery, and Psychiatry·D SIMPSON

❮ Previous
Next ❯

Citations

Jul 1, 1989·Journal of Neuro-oncology·T HoshinoC B Wilson
Jan 1, 1994·Journal of Neuro-oncology·R Desai, J Bruce
Jan 1, 1994·Journal of Neuro-oncology·A FreeseM J O'Connor
Jan 1, 1992·Journal of Cancer Research and Clinical Oncology·B Maurer-SchultzeM Harasim
Jan 1, 1990·Acta neurochirurgica·K A BusheW Dittmann
Jan 1, 1989·Acta neurochirurgica·P K GuptaB S Das
Jan 1, 1992·Acta neurochirurgica·J MeixensbergerE Hofmann
Oct 6, 1997·International Journal of Radiation Oncology, Biology, Physics·K S CondraA L Rhoton
May 14, 2004·The Neurologist·Katharine J DrummondPeter McL Black
Sep 1, 1989·Journal of Neurosurgery·T HoshinoR L Davis
Jul 1, 1990·Journal of Neurosurgery·K KajiwaraH Ito
Oct 1, 1990·Journal of Neurosurgery·R P FirschingN Klug
May 1, 1996·Journal of Neurosurgery·M C Chamberlain
Oct 1, 1996·Journal of Neurosurgery·A R RezaiF J Epstein
Dec 10, 1997·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·J SmolleH Kerl
May 1, 1988·European Journal of Cancer & Clinical Oncology·M DanovaP Paoletti
Sep 15, 1986·International Journal of Cancer. Journal International Du Cancer·T HoshinoL H Pitts
Dec 6, 2001·Arquivos de neuro-psiquiatria·A FalavignaA de P Bonatelli Ad
Apr 1, 1992·Surgical Neurology·L I de Ridder, L J Calliauw
Jan 1, 1989·British Journal of Neurosurgery·H P SiegersN de Tribolet
Jan 1, 1993·British Journal of Neurosurgery·S ChatterjeeR V Jeffreys
Aug 1, 1992·Cancer·S ItoM S Edwards

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.